Striatal FP-CIT uptake differs in the subtypes of early Parkinson’s disease Authors
First Online: 24 May 2006 Received: 11 March 2006 Accepted: 19 April 2006 DOI:
Cite this article as: Spiegel, J., Hellwig, D., Samnick, S. et al. J Neural Transm (2007) 114: 331. doi:10.1007/s00702-006-0518-2 Summary.
In idiopathic Parkinson’s disease (PD), a tremor-dominant type (TDT), an akinetic-rigid type (ART), and a mixed type (MT) are distinguished. We compared cerebral [I-123]FP-CIT SPECT in the PD subtypes (67 patients Hoehn and Yahr stage 1:26 with ART, 19 with MT, 22 with TDT). We measured the ratios putamen/occipital lobe binding and caudate nucleus/occipital lobe binding. Parkinsonian motor symptoms were quantified by UPDRS motor scale. In both putamen and caudate nucleus contralateral to the clinically affected body side TDT patients showed a significantly higher FP-CIT uptake than ART or MT patients (ANOVA;
p<0.01). Contralateral putamen and caudate nucleus FP-CIT uptake correlated significantly with severity of rigidity ( p<0.01) and hypokinesia ( p<0.01) but not with severity of resting or postural tremor ( p>0.05). The missing correlation between striatal FP-CIT uptake and tremor suggests, that further systems besides the nigrostriatal dopaminergic system may contribute to generation of parkinsonian tremor. Keywords: Parkinson’s disease, FP-CIT SPECT References Asenbaum, S, Pirker, W, Angelberger, P, Bencsits, G, Pruckmayer, M, Brücke, T 1998 [123I]β-CIT SPECT in essential tremor and Parkinson’s disease J Neural Transm 105 1213 1228 PubMed CrossRef Benamer, HTS, Patterson, J, Grosset, DG 2000a Accurate differentiation of parkinsonian and essential tremor using visual assessment of [123I]-FP-CIT-SPECT imaging: the [123I]-FP-CIT study group Mov Disord 15 503 510 CrossRef Benamer, HTS, Patterson, J, Wyper, DJ, Hadley, DM, MacPhee, GJA, Grosset, DG 2000b Correlation of Parkinson’s disease severity and duration with 123I-FP-CIT SPECT striatal uptake Mov Disord 15 692 698 CrossRef Benamer, HTS, Oertel, WH, Patterson, J, Hadley, DM, Pogareff, O, Hoffken, H, Gerstner, A, Grosset, DG 2003 Prospective study of presynaptic dopaminergic imaging in patients with mild parkinsonism and tremor disorders: Part 1. baseline and 3-month observations Mov Disord 18 977 984 PubMed CrossRef Booij, J, Sokole, EB, Stabin, MG, Janssen, AGM, de Bruin, K, van Royen, EA 1998 Human biodistribution and dosimetry of [123I]FP-CIT: a potential radioligand for imaging of dopamine transporters Eur J Nucl Med 25 24 30 PubMed CrossRef Fahn, S Elton, RL and members of the UPDRS Development Committee 1987 Unified Parkinson’s disease rating scale Fahn, S Marsden, CD Calne, DB Goldstein, M eds. Recent developments in Parkinson’s disease Macmillan Healthcare Information Florham Park, HJ 153 164 Hoehn, MM, Yahr, MD 1967 Parkinsonism: onset, progression and mortality Neurology 17 427 442 PubMed CrossRef Hughes, A, Daniel, SE, Kilford, L, Lees, AJ 1992 Accuracy of clinical diagnosis of idiopathic Parkinson’s disease: a clinico-pathological study of 100 cases J Neurol Neurosurg Psychiatry 55 181 184 PubMed CrossRef Ichise, M, Kim, YJ, Ballinger, JR, Vines, D, Erami, SS, Tanaka, F, Lang, AE 1999 SPECT imaging of pre- and postsynaptic dopaminergic alterations in L-dopa untreated Parkinson’s disease Neurology 52 1206 1214 PubMed Kim, YJ, Ichise, M, Ballinger, JR, Vines, D, Erami, SS, Tatschida, T, Lang, AE 2002 Combination of dopamine transporter and D2 receptor SPECT in the diagnostic evaluation of PD, MSA and PSP Mov Disord 17 303 312 PubMed CrossRef Korchounov, A, Schipper, HI, Preobrazhenskaya, IS, Kessler, KR, Yakhno, NN 2004 Differences in age at onset and familial aggregation between clinical types of idiopathic Parkinson’s disease Mov Disord 19 1059 1064 PubMed CrossRef Laruelle, M, Baldwin, RM, Malison, RT, Zea-Ponce, Y, Zogbhi, SS, Al-Tikriti, MS, Sybirska, EH, Zimmermann, RC, Wisniewski, G, Neumeyer, JL 1993 SPECT imaging of dopamine and serotonin transporters with [123I]ß-CIT: pharmacological characterization of brain uptake in non-human primates Synapse 13 295 309 PubMed CrossRef Lewis, SJG, Foltynie, T, Blackwell, AD, Robbins, TW, Owen, AM, Barker, RA 2005 Heterogeneity of Parkinson’s disease in the early clinical stages using a data driven approach J Neurol Neurosurg Psychiatry 76 343 348 PubMed CrossRef Otsuka, M, Ichiya, Y, Kuwabara, Y, Hosokawa, S, Sasaki, M, Yoshida, T, Fukumura, T, Masuda, K, Kato, M 1996 Differences in the reduced 18F-Dopa uptakes of the caudate and the putamen in Parkinson’s disease: correlations with the three main symptoms J Neurol Sci 136 169 173 PubMed CrossRef Pirker, W, Asenbaum, S, Bencsits, G, Prayer, D, Gerschlager, W, Deecke, L, Brucke, T 2000 [123I]beta-CIT SPECT in multiple system atrophy, progressive supranuclear palsy, and corticobasal degeneration Mov Disord 15 1158 1167 PubMed CrossRef Pirker, W 2003 Correlation of dopamine transporter imaging with parkinsonian motor handicap: how close is it? Mov Disord 18 S43 S51 PubMed CrossRef Rinne, JO, Ruottinen, H, Bergman, J, Haaparanta, M, Sonninen, P, Solin, O 1999 Usefulness of a dopamine transporter PET ligand [(18)F]beta-CFT in assessing disability in Parkinson’s disease J Neurol Neurosurg Psychiatry 67 737 741 PubMed CrossRef Seibyl, JP, Marek, KL, Quinlan, D, Sheff, K, Zoghbi, S, Zea-Ponce, Y, Baldwin, RM, Fussell, B, Smith, EO, Charney, DS 1995 Decreased single photon emission computed tomography [123I]ß-CIT striatal uptake correlates with symptom severity in Parkinson’s disease Ann Neurol 38 589 598 PubMed CrossRef Spiegel, J, Mollers, MO, Jost, WH, Fuss, G, Samnick, S, Dillmann, U, Becker, G, Kirsch, CM 2005 FP-CIT and MIBG scintigraphy in early Parkinson’s disease Mov Disord 20 552 561 PubMed CrossRef Vingerhoets, FJ, Schulzer, M, Calne, DB, Snow, BJ 1997 Which clinical sign of Parkinson’s disease best reflects the nigrostriatal lesion? Ann Neurol 41 58 64 PubMed CrossRef Winogrodzka, A, Bergmans, P, Booij, J, van Royen, EA, Janssen, AGM, Wolters, EC 2001 [123I]FP-CIT SPECT is a useful method to monitor the rate of dopaminergic degeneration in early-stage Parkinson’s disease J Neural Transm 108 1011 1019 PubMed CrossRef